| Discharge Regimen | Year of Transplant | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | ||
| Total | Patients | 4,075 | 4,726 | 5,188 | 5,354 | 5,508 | 5,682 | 5,553 | 5,514 | 5,167 | 5,139 |
| Steroids Avoided | 118 | 262 | 464 | 630 | 1,015 | 1,607 | 1,815 | 2,087 | 2,119 | 2,087 | |
| Rate | 2.9% | 5.5% | 8.9% | 11.8% | 18.4% | 28.3% | 32.7% | 37.8% | 41.0% | 40.6% | |
| CyA | Patients | 235 | 167 | 123 | 80 | 104 | 122 | 26 | 28 | 21 | 6 |
| Steroids Avoided | 1 | 4 | 8 | 4 | 10 | 20 | 6 | 10 | 3 | 2 | |
| Rate | 0.4% | 2.4% | 6.5% | 5.0% | 9.6% | 16.4% | 23.1% | 35.7% | 14.3% | 33.3% | |
| Tac | Patients | 120 | 203 | 220 | 233 | 191 | 197 | 137 | 191 | 186 | 166 |
| Steroids Avoided | 5 | 30 | 46 | 87 | 64 | 68 | 57 | 112 | 97 | 92 | |
| Rate | 4.2% | 14.8% | 20.9% | 37.3% | 33.5% | 34.5% | 41.6% | 58.6% | 52.2% | 55.4% | |
| CyA+MMF | Patients | 2,047 | 1,924 | 1,640 | 1,303 | 1,121 | 954 | 710 | 502 | 412 | 318 |
| Steroids Avoided | 36 | 64 | 66 | 45 | 111 | 123 | 112 | 117 | 116 | 61 | |
| Rate | 1.8% | 3.3% | 4.0% | 3.5% | 9.9% | 12.9% | 15.8% | 23.3% | 28.2% | 19.2% | |
| Tac+MMF | Patients | 1,019 | 1,396 | 1,977 | 2,594 | 2,881 | 3,339 | 3,843 | 3,971 | 3,981 | 4,154 |
| Steroids Avoided | 48 | 73 | 132 | 261 | 477 | 1,006 | 1,336 | 1,575 | 1,700 | 1,710 | |
| Rate | 4.7% | 5.2% | 6.7% | 10.1% | 16.6% | 30.1% | 34.8% | 39.7% | 42.7% | 41.2% | |
| CyA+Aza | Patients | 270 | 186 | 145 | 51 | 20 | 14 | 5 | 6 | 8 | 3 |
| Steroids Avoided | 7 | 3 | 2 | 0 | 1 | 1 | 1 | 1 | 7 | 2 | |
| Rate | 2.6% | 1.6% | 1.4% | 0.0% | 5.0% | 7.1% | 20.0% | 16.7% | 87.5% | 66.7% | |
| Tac+Aza | Patients | 61 | 60 | 84 | 82 | 70 | 41 | 9 | 17 | 14 | 13 |
| Steroids Avoided | 3 | 5 | 11 | 6 | 7 | 6 | 3 | 7 | 2 | 3 | |
| Rate | 4.9% | 8.3% | 13.1% | 7.3% | 10.0% | 14.6% | 33.3% | 41.2% | 14.3% | 23.1% | |
| CyA+Siro | Patients | 60 | 260 | 170 | 142 | 168 | 129 | 148 | 135 | 90 | 89 |
| Steroids Avoided | 0 | 1 | 5 | 30 | 60 | 81 | 103 | 112 | 67 | 62 | |
| Rate | 0.0% | 0.4% | 2.9% | 21.1% | 35.7% | 62.8% | 69.6% | 83.0% | 74.4% | 69.7% | |
| Tac+Siro | Patients | 6 | 217 | 429 | 382 | 370 | 324 | 210 | 253 | 67 | 32 |
| Steroids Avoided | 0 | 22 | 103 | 94 | 115 | 145 | 78 | 65 | 29 | 24 | |
| Rate | 0.0% | 10.1% | 24.0% | 24.6% | 31.1% | 44.8% | 37.1% | 25.7% | 43.3% | 75.0% | |
| Siro+MMF | Patients | 1 | 45 | 109 | 152 | 154 | 109 | 132 | 85 | 53 | 61 |
| Steroids Avoided | 0 | 12 | 8 | 6 | 22 | 26 | 20 | 16 | 10 | 14 | |
| Rate | 0.0% | 26.7% | 7.3% | 3.9% | 14.3% | 23.9% | 15.2% | 18.8% | 18.9% | 23.0% | |
| Other Regimen | Patients | 256 | 268 | 291 | 335 | 429 | 453 | 333 | 326 | 335 | 297 |
| Steroids Avoided | 18 | 48 | 83 | 97 | 148 | 131 | 99 | 72 | 88 | 117 | |
| Rate | 7.0% | 17.9% | 28.5% | 29.0% | 34.5% | 28.9% | 29.7% | 22.1% | 26.3% | 39.4% | |